BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29093987)

  • 1. Targeting the epitope spreader Pep19 by naïve human CD45RA
    Kim HJ; Cha GS; Joo JY; Lee J; Kim SJ; Lee J; Park SY; Choi J
    J Periodontal Implant Sci; 2017 Oct; 47(5):292-311. PubMed ID: 29093987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD49d Treg cells with high suppressive capacity are remarkably less efficient on activated CD45RA- than on naive CD45RA+ Teff cells.
    Kraczyk B; Remus R; Hardt C
    Cell Physiol Biochem; 2014; 34(2):346-55. PubMed ID: 25060807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
    DeOca KB; Moorman CD; Garcia BL; Mannie MD
    Front Immunol; 2020; 11():541619. PubMed ID: 33072087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD4
    Brown ME; Peters LD; Hanbali SR; Arnoletti JM; Sachs LK; Nguyen KQ; Carpenter EB; Seay HR; Fuhrman CA; Posgai AL; Shapiro MR; Brusko TM
    Front Immunol; 2022; 13():873560. PubMed ID: 35693814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25
    Wilkinson DS; Ghosh D; Nickle RA; Moorman CD; Mannie MD
    Front Immunol; 2017; 8():1782. PubMed ID: 29312311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
    Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
    Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
    Jiang S; Tsang J; Lechler RI
    Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of human regulatory T-cells from patients with type 1 diabetes.
    Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
    Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function.
    Ma X; Cao L; Raneri M; Wang H; Cao Q; Zhao Y; Bediaga NG; Naselli G; Harrison LC; Hawthorne WJ; Hu M; Yi S; O'Connell PJ
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37874660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providence of the CD25
    Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
    Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
    Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
    Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.
    van Herwijnen MJ; van der Zee R; van Eden W; Broere F
    PLoS One; 2015; 10(6):e0128373. PubMed ID: 26107957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
    Huang H; Dawicki W; Zhang X; Town J; Gordon JR
    J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.
    Hoffmann P; Eder R; Boeld TJ; Doser K; Piseshka B; Andreesen R; Edinger M
    Blood; 2006 Dec; 108(13):4260-7. PubMed ID: 16917003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients.
    Barberá A; Lorenzo N; van Kooten P; van Roon J; de Jager W; Prada D; Gómez J; Padrón G; van Eden W; Broere F; Del Carmen Domínguez M
    Cell Stress Chaperones; 2016 Jul; 21(4):735-44. PubMed ID: 27241313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.